Research centres will accelerate development of late-stage research within NHS
Agreement follows positive phase III data announcement
Treatment recommended for acquired thrombotic thrombocytopenic purpura
The UK government delayed the findings of a Public Health England (PHE) study that question the accuracy of […]
A long acting form of the drug cabotegravir, which is taken once every eight weeks, is safe and […]
Médecins Sans Frontières (MSF) has called on governments to demand transparency from pharmaceutical companies on covid-19 vaccine licensing […]
Legal action has been launched over the UK government’s award of a £75m (€84m; $99m) contract for one […]
COVID antibody drugs from Lilly and Regeneron won’t do much to boost their top lines: analysts arlene.weintraub Thu, […]
Generics players join pledge to rapidly scale access to COVID-19 drugs. But will pharma sign on? kblankenship Thu, […]
AstraZeneca’s Calquence fails COVID-19 study, joining the list of repurposed meds that have fallen short esagonowsky Thu, 11/12/2020 […]